Instituto de Investigación Sanitaria de Navarra-ko ikertzaileekin lankidetzan egindako argitalpenak (14)

2023

  1. Liver Resection and Transplantation Following Yttrium-90 Radioembolization for Primary Malignant Liver Tumors: A 15-Year Single-Center Experience

    Cancers, Vol. 15, Núm. 3

  2. Understanding of Flow Allows Better Tumor Microsphere Coverage

    Journal of Vascular and Interventional Radiology

2022

  1. A new animal model of atrophy–hypertrophy complex and liver damage following Yttrium-90 lobar selective internal radiation therapy in rabbits

    Scientific Reports, Vol. 12, Núm. 1

  2. Computational Fluid Dynamics Modeling of Liver Radioembolization: A Review

    CardioVascular and Interventional Radiology, Vol. 45, Núm. 1, pp. 12-20

  3. Computational Study of the Microsphere Concentration in Blood during Radioembolization

    Mathematics, Vol. 10, Núm. 22

  4. Pure laparoscopic major liver resection after yttrium90 radioembolization: a case-matched series analysis of feasibility and outcomes

    Langenbeck's Archives of Surgery, Vol. 407, Núm. 3, pp. 1099-1111

2021

  1. A proof-of-concept study of the in-vivo validation of a computational fluid dynamics model of personalized radioembolization

    Scientific Reports, Vol. 11, Núm. 1

  2. Cfd simulations of radioembolization: A proof-of-concept study on the impact of the hepatic artery tree truncation

    Mathematics, Vol. 9, Núm. 8

2020

  1. Impact of the dosimetry approach on the resulting 90Y radioembolization planned absorbed doses based on 99mTc-MAA SPECT-CT: is there agreement between dosimetry methods?

    EJNMMI Physics, Vol. 7, Núm. 1

  2. The Pattern of Progression Defines Post-progression Survival in Patients with Hepatocellular Carcinoma Treated with SIRT

    CardioVascular and Interventional Radiology, Vol. 43, Núm. 8, pp. 1165-1172

2018

  1. Significant dose reduction is feasible in FDG PET/CT protocols without compromising diagnostic quality

    Physica Medica, Vol. 46, pp. 134-139

2017

  1. Effective dose estimation for oncological and neurological PET/CT procedures

    EJNMMI Research, Vol. 7, Núm. 1

2016

  1. Index lesion characterization by 11C-Choline PET/CT and Apparent Diffusion Coefficient parameters at 3 Tesla MRI in primary prostate carcinoma

    Prostate, Vol. 76, Núm. 1, pp. 3-12

2015

  1. Radioembolization with 90Y-microspheres for liver tumors

    Revista Espanola de Medicina Nuclear e Imagen Molecular, Vol. 34, Núm. 4, pp. 244-257